Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p

References

• Shen Z, Li Q, Deng H, et al. Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC. Plos One. 2014;9(9):e108237.
   PubMed Web of Science ®Google Scholar
• Pizem J, Cör A, Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology. 2010;45(2):180–186.
   Google Scholar
• Luo J, Wu J, Li Z, et al. miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma. Biomed Res Int. 2014;2014(2014):374598.
   PubMedGoogle Scholar
• Lionello M, Staffieri A, Marioni G. Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma. Acta Otolaryngol. 2012;132(6):574–582.
   PubMed Web of Science ®Google Scholar
• Chen. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Oncol Rep. 2009;22(1):89–95.
   PubMed Web of Science ®Google Scholar
• Dirix P, Lambrecht M, Nuyts S. Radiotherapy for laryngeal squamous cell carcinoma: current standards. Expert Rev Anticancer Ther. 2010;10(9):1461.
   PubMed Web of Science ®Google Scholar
• Loo SW, Geropantas K, Roques TW. Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy? Clin Oncol. 2013;25(5):298–307.
   Web of Science ®Google Scholar
• van Bockel Lw, Verduijn GM, Monninkhof EM, et al. The importance of actual tumor growth rate on disease free survival and overall survival in laryngeal squamous cell carcinoma. Radiotherapy & Oncology Journal of the European Society for Therapeutic Radiology & Oncology. 2014;112(1):119–124.
   PubMed Web of Science ®Google Scholar
• Wei G, Yongyan W, Xiaoling H, et al. MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1. J Cancer. 2017;8(12):2356–2368.
   PubMed Web of Science ®Google Scholar
• Jin YT, Kayser S, Kemp BL, et al. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl‐2 in laryngeal squamous cell carcinoma. Cancer. 2015;82(11):2159–2165.
   Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338.
   PubMed Web of Science ®Google Scholar
• Salzman J, Gawad C, Wang PL, et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. Plos One. 2012;7(2):e30733.
   PubMed Web of Science ®Google Scholar
• Guo JU, Agarwal V, Guo H, et al. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014;15(7):409.
   PubMed Web of Science ®Google Scholar
• Lu C, Shi X, Wang AY, et al. RNA-Seq profiling of circular RNAs in human laryngeal squamous cell carcinomas. Mol Cancer. 2018;17(1):86.
   PubMed Web of Science ®Google Scholar
• Xia W, Qiu M, Chen R, et al. Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation. Sci Rep. 2016;6(1):35576.
   PubMedGoogle Scholar
• Peng L, Chen G, Zhu Z, et al. Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease. Oncotarget. 2017;8(1):808.
   PubMedGoogle Scholar
• Li M, Li Y, Yu M. CircRNA ZNF609 knockdown suppresses cell growth via modulating miR-188/ELF2 axis in nasopharyngeal carcinoma[J]. Onco Targets Ther. 2020;13:2399–2409.
   PubMed Web of Science ®Google Scholar
• Zhong X, Coukos G, Zhang L. miRNAs in human cancer. J Pathol. 2015;223(2):102–115.
   Google Scholar
• Foekens JA, Sieuwerts AM, Smid M, et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci U S A. 2008;105(35):13021–13026.
   PubMed Web of Science ®Google Scholar
• Meister G. miRNAs get an early start on translational silencing. Cell. 2007;131(1):25–28.
   PubMed Web of Science ®Google Scholar
• Shen Z, Zhan G, Ye D, et al. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol. 2012;29(4):2473–2480.
   PubMed Web of Science ®Google Scholar
• Xiao X, Zhou L, Cao P, et al. MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma. Int J Oncol. 2015;46(1):161–174.
   PubMed Web of Science ®Google Scholar
• Tuncturk FR, Akalin I, Uzun L, et al. Comparison of miRNA expressions among benign, premalignant and malignant lesions of the larynx: could they be transformation biomarkers?[J]. Journal of otolaryngology - head & neck surgery = Le Journal d’oto-rhino-laryngologie et de chirurgie cervico-faciale. 2021;50(1): 14.
   PubMed Web of Science ®Google Scholar
• Cui W, Meng W, Zhao L, et al. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis[J]. Int J Oncol. 2019;54(6).
   Web of Science ®Google Scholar
• Gacoń J, Badacz R, Stępień E, et al. Diagnostic and prognostic micro-RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study. Kardiol Pol. 2018;38(suppl_1).
   Google Scholar
• Tong H, Zhao K, Wang J, et al. CircZNF609/miR-134-5p/BTG-2 axis regulates proliferation and migration of glioma cell. J Pharm Pharmacol. 2020;72(1):68–75.
   PubMed Web of Science ®Google Scholar
• Chi J, Liu T, Shi C, et al. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis[J]. Biomed Pharmacothe. 2019;118:109201.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR-7 in cancer. Cancer Res. 2013;73(18):5609–5612.
   PubMed Web of Science ®Google Scholar
• Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380.
   PubMed Web of Science ®Google Scholar
• Guenin S, Mauriat M, Pelloux J, et al. Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. J Exp Bot. 2009;60(2):487–493.
   PubMed Web of Science ®Google Scholar
• lncRNA IGKJ2‐MALLP2 suppresses LSCC proliferation, migration, invasion, and angiogenesis by sponging miR‐1911‐3p/p21. Cancer Sci. 2020.
   Web of Science ®Google Scholar
• Sayre KR, Dodd RY, Tegtmeier G, et al. False-positive human immunodeficiency virus type 1 Western blot tests in noninfected blood donors. Transfusion. 2010;36(1):45–52.
   Google Scholar
• Busch A, Richter AS, Backofen R. IntaRNA: efficient prediction of bacterial sRNA targets incorporating target site accessibility and seed regions. Bioinformatics. 2008;24(24):2849–2856.
   PubMed Web of Science ®Google Scholar
• Oktem F, Yazicilar O, Güvenç M, et al. Urinary N-acetyl-beta-D-glucosaminidase levels in patients with laryngeal squamous cell carcinoma. J Otolaryngol. 2007;36(36):233–239.
   PubMedGoogle Scholar
• Li D, Feng J, Wu T, et al. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. The American Journal of Pathology. 2013;182(1):64–70.
   PubMed Web of Science ®Google Scholar
• Guo XD, Lan SM, Cao JZ, et al. Retrospective analysis of prognostic factors in laryngeal squamous cell carcinoma. Chinese Journal of Cancer Prevention & Treatment. 2011;18(8): 606–609.
   Google Scholar
• Almadori G, Bussu F, Paludetti G. Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecularclassification. Acta Otorhinolaryngologica Italica. 2006;26(6):326.
   PubMedGoogle Scholar
• Dong Y, Sui LWY, Katsuyoshi S, et al. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res. 2002;22(4):2377.
   PubMed Web of Science ®Google Scholar
• Almadori G, Bussu F, Cadoni G, et al. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer. 2005;41(5):683–693.
   PubMed Web of Science ®Google Scholar
• Rui Z, Feng-Qing L, Lin-Li T, et al. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA–lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma. Funct Integr Genomics. 2018;19(Suppl):1–13.
   PubMedGoogle Scholar
• Jia-Jian W, Chang L, Kun S, et al. Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge. Theranostics. 2018;8(12):3408–3415.
   PubMed Web of Science ®Google Scholar
• Wang S, Xue X, Wang R, et al. CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p. Cancer Manag Res. 2018;10:3881–3890.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu F, Wang F, et al. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p. Mol Cell Biochem. 2021;476(1):175–186.
   PubMed Web of Science ®Google Scholar
• Rong D, Sun H, Li Z, et al. An emerging function of circRNA-miRNAs-mRNAaxis in human diseases. Oncotarget. 2017;8(42):73271–73281.
   PubMedGoogle Scholar
• Hsei-Wei W, Shu-Han S, Yen-Li W, et al. MicroRNA-134 contributes to glucose-induced endothelial cell dysfunction and this effect can be reversed by far-infrared irradiation. Plos One. 2016;11(1):e0147067.
   PubMed Web of Science ®Google Scholar
• Carcereny E, Morán T, Capdevila L, et al. The epidermal growth factor receptor (EGRF) in lung cancer. Transl Respir Med. 2015;3(1):1–8.
   PubMedGoogle Scholar
• Rolfo C, Russo A, Santini D, et al. Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting. Expert Opin Ther Targets. 2013;17(8):869–871.
   PubMed Web of Science ®Google Scholar
• Qin Q, Wei F, Zhang J, et al. miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor. J Cell & Mol Med. 2016;20(10):1974–1983.
   PubMed Web of Science ®Google Scholar